BioSpace News Archive

Call to be held on Thursday, December 17th at 11:00am EST

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the selection of three abstracts for presentation at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, taking place virtually on January 15 – 17, 2021.

Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced two presentations at the 59th Annual Meeting for the American College of Neuropsychopharmacology (ACNP)

SUSS MicroTec, a leading supplier of equipment and process solutions for the semiconductor industry and related markets, announces the launch of its latest generation mask aligner, the MA8 Gen5.

SUGAR LAND, TX / ACCESSWIRE / December 10, 2020 / Neutra Corp. (OTC PINK:NTRR) retail subsidiary VIVIS is launching its pain cream which has been in its test market for the past few months. “It took a while to get the formula down just the way we like it,” said Neutra CEO Sydney Jim. “Our pain cream is a tad more mild in menthol but we have doubled the concentration of CBD per application and added a few more ingredients that are great for pain management.” VIVIS products

Cerner Corporation, a global health care technology company, announced it’s building on the recent collaboration with Xealth to offer health systems new centralized digital ordering and monitoring for clients.

Evommune, Inc., a private R&D company and innovation engine in chronic inflammation, and Axcelead Drug Discovery Partners, Inc. (Axcelead), a Japanese solution provider in drug discovery research, today announced they have started an exclusive partnership for a late-stage discovery program.

Today, Ginkgo Bioworks , Inc. (“Ginkgo”) and Octant, Inc (“Octant”) announced a partnership to grow critical diagnostic testing capacity to address the COVID-19

MSN Labs, based in Hyderabad India, recently received FDA approval to market their generic versions of Toremifene 60mg tablets, (AB rated to Kyowa Kirin’s Fareston©) & Aminocaproic Acid 500mg tablet, (AB rated Clover’s Amicar©) under the Novadoz label.

Molecular diagnostics company Lucence today announced that the company’s Palo Alto laboratory received certification from the U.S. Department of Health and Human Services’ Centers for Medicare & Medicaid Services (CMS) under the Clinical Laboratory Improvement Amendments (CLIA) of 1988.